Luminor Medical Technologies

Canada
Victoriaville, Quebec, Canada, R3T 6C6

Company profile

Luminor Medical Technologies company profile

Luminor Medical Technologies is a medical diagnostic company, focuses on acquiring, developing, and commercializing non-invasive tests for unmet clinical needs in Canada. The company’s products and services include PREVU Skin Cholesterol Test, a non-invasive test that measures cholesterol in the skin tissues to assess risk of coronary artery disease or heart disease; PSP94, an enzyme linked immunosorbent assay for urine specimens; and testing services. Its diagnostic programs under development comprise cardiovascular disease, preeclampsia, prostate cancer, colorectal cancer, pancreatic cancer, and gastric cancer programs. The company has a partnership agreement with Alere, Inc. for the development of tests for preeclampsia biomarkers.

Business identity

Contact email
[email protected]
Phone number
204-453-1370
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
1998-01-01

Headquarters

Postal code
R3T 6C6
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$1.2M
Last funding
Post IPO Debt / $175,000 / 2016-10-24
Last equity funding
Post IPO Equity / $306,750
Articles
2
Exited on
2016-04-14

Founders and investors

No public relation records are available.